Navigating the Tricky Climate of Health Tech Funding
Getting would-be investors—and the right kind of investors—to notice and care about your company requires a robust strategy.
Providence Spins Out New Patient Engagement Startup With $20M in Funding
Providence spun out its fourth digital health startup: Praia Health, a platform designed to build stronger relationships with patients by personalizing their healthcare journeys and connecting them to relevant resources and services. The startup also announced the closing of a $20 million Series A funding round led by Frist Cressey Ventures.
Health Executives on Digital Transformation in Healthcare
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Forta Health Rakes In $55M to Empower Family Caregivers
Forta Health raised $55 million in Series A funding on Wednesday. The startup offers a platform to help family caregivers quickly access care to manage their loved ones' chronic conditions. Its first area of focus is autism spectrum disorder (ASD).
Ketryx Rakes In $14M to Speed Up Medical Device Development & Quality Assurance
Ketryx raised $14 million in Series A funds. The startups sells a platform — designed around FDA regulations and quality standards — that automates much of the work required from medical device companies’ development and quality teams.
Bright Uro Snags $23M To Make Urology Diagnostics Easier for Providers & Patients
Bright Uro raised $23 million in Series A funds to help achieve FDA clearance for its urodynamics system and launch the product in the U.S. Should it be cleared, the system will become the first product on the market able perform urodynamic monitoring wirelessly and without a catheter, the company's CEO said.
Allara Snags $10M to Scale Its Platform for Women’s Chronic Hormonal Conditions
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women's chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Medicare Startup Prioritizing ‘Movement As Medicine’ Snags $17M
Bold, a Los Angeles-based company offering a healthy aging platform for older adults, closed a $17 million Series A funding round. The startup seeks to improve the health of Medicare Advantage beneficiaries through personalized exercise programs designed to prevent falls, decrease musculoskeletal pain and boost physical activity levels.
Patient navigation platform Rightway Healthcare lands $8M Series A
The startup intends to use the money to expand its sales team, enter new markets and increase the breadth of its product offering.
Medication management startup Hero launches with $12M in funding
The startup's product, which is also called Hero, sorts and dispenses medication, automates refills and offers audible and digital reminders.
ExplORer Surgical unveils $3 million Series A round
Aphelion Capital led the round for the Chicago-based startup, whose solution focuses on improving communication and coordination in the operating room.
Reducing Clinical and Staff Burnout with AI Automation
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
Circulation secures $10.5 million in funding
Circulation, a Boston-based startup focused on the non-emergency medical transportation space, said it has raised $10.5 million from investors such as Boston Children's Hospital, Humana and Intermountain Healthcare Innovation Fund.
Scholar Rock raises $20M for its targeted growth factor therapies
Targeting the growth factors that influence cell proliferation and differentiation in disease is a pretty “well-trodden” field, but Cambridge biotech Scholar Rock purports to take a new spin on the concept. It’s announced a $20 million Series A financing round, and plans to use the funds to move its preclinical work into clinical drug development. Scholar Rock is […]
Startup’s drug could help preemies breathe easy
Bronchopulmonary dysplasia is a common condition among premature infants that require ventilation after birth. It causes inflammation and scarring in their delicate lungs, leading to serious complications at the earliest and most critical stages of a preemie’s development. Cincinnati-based Airway Therapeutics has raised $4.6 million in Series A financing for its new treatment, AT-100, that prevents BPD in preemies. The company has developed a […]